Oxybutynin Hydrochloride is used for: Overactive bladder.
Recorded in the NepalDoc medicine catalog for Oxybutynin Hydrochloride.
Oxybutynin chloride extended-release tablets are a muscarinic antagonist indicated for the treatment of overactive bladder with symptoms of urge urinary incontinence, urgency, and frequency. Oxybutynin chloride extended-release tablets are also indicated for the treatment of pediatric patients aged 6 years and older with symptoms of detrusor overactivity associated with a neurological condition (e.g., spina bifida).
From the U.S. FDA-approved label for Oxybutynin Hydrochloride. Full label: DailyMed.
Oxybutynin chloride extended-release tablets are a muscarinic antagonist indicated for the treatment of overactive bladder with symptoms of urge urinary incontinence, urgency, and frequency. Oxybutynin chloride extended-release tablets are also indicated for the treatment of pediatric patients aged 6 years and older with symptoms of detrusor overactivity associated with a neurological condition (e.g., spina bifida).
From the U.S. FDA-approved label for Oxybutynin Hydrochloride. Full label: DailyMed.
Oxybutynin chloride extended-release tablets must be swallowed whole with the aid of liquids, and must not be chewed, divided, or crushed. Oxybutynin chloride extended-release tablets may be administered with or without food. Oxybutynin chloride extended-release tablets must be swallowed whole with the aid of liquids, and must not be chewed, divided, or crushed.
Directions from the U.S. FDA-approved label for Oxybutynin Hydrochloride — your doctor or pharmacist may advise differently.
Oxybutynin chloride extended-release tablets are contraindicated in patients with urinary retention, gastric retention and other severe decreased gastrointestinal motility conditions, uncontrolled narrow-angle glaucoma. Oxybutynin chloride extended-release tablets are also contraindicated in patients who have demonstrated hypersensitivity to the drug substance or other components of the product. There have been reports of hypersensitivity reactions, including anaphylaxis and angiodema.
Excerpt from the U.S. FDA-approved label for Oxybutynin Hydrochloride. Talk to a pharmacist or doctor before use.
Angioedema: Angioedema has been reported with oxybutynin. If symptoms of angioedema occur, discontinue Oxybutynin chloride extended-release tablets immediately and initiate appropriate therapy. Central Nervous System (CNS) effects: CNS effects have been reported with oxybutynin. If patient experiences anticholinergic CNS effects, consider dose adjustment or discontinuation of Oxybutynin chloride extended-release tablets.
Warnings and precautions excerpt from the U.S. FDA-approved label for Oxybutynin Hydrochloride — not a complete list. Talk to a pharmacist or doctor before use.
The most common (incidence ≥5%) adverse reactions were dry mouth, constipation, diarrhea, headache, somnolence, and dizziness. To report SUSPECTED ADVERSE REACTIONS, contact AvKARE, Inc. at 1-855-361-3993 or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch.
Excerpt from the U.S. FDA-approved label for Oxybutynin Hydrochloride — not a complete list. Talk to a pharmacist or doctor about side effects.
11 brands · 5 makers in the NepalDoc catalog — see the full Oxybutynin Hydrochloride guide →
16.1 Storage Store at 25°C (77°F); excursions permitted to 15–30°C (59–86°F). Protect from moisture and humidity.
Storage information from the U.S. FDA-approved label for Oxybutynin Hydrochloride.
What is Nocturin?
Nocturin 2.5mg Tablet is a Oxybutynin Hydrochloride medicine made by Elder Pharmaceuticals. It comes as 2.5mg Tablet.
What is Nocturin used for?
Oxybutynin Hydrochloride is used for Overactive bladder.
What is the generic name of Nocturin?
The generic name of Nocturin is Oxybutynin Hydrochloride.
Which brands of Oxybutynin Hydrochloride are available in Nepal?
11 brands of Oxybutynin Hydrochloride are listed in the NepalDoc catalog, from 5 makers — including Cystran 2.5mg Tablet, Cystran 5mg Tablet, Nocturin 5mg Tablet, Oxyflow 2.5mg Tablet, Oxyflow 5mg Tablet, Oxyspas 2.5mg Tablet.
What are the side effects of Oxybutynin Hydrochloride?
The most common (incidence ≥5%) adverse reactions were dry mouth, constipation, diarrhea, headache, somnolence, and dizziness. To report SUSPECTED ADVERSE REACTIONS, contact AvKARE, Inc. at 1-855-361-3993 or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch.
This page is information only and is not medical advice. Medicine details come from the sources listed above and may change — always confirm the medicine, strength and dose with a pharmacist or doctor before use. A catalog listing does not guarantee that a medicine is in stock at any pharmacy.
